Quick View
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥467.1B | ¥466.2B | +0.2% |
| Operating Income | ¥26.1B | ¥26.1B | +0.1% |
| Ordinary Income | ¥35.1B | ¥30.8B | +13.9% |
| Net Income | ¥17.3B | ¥19.8B | −12.6% |
| ROE | 2.5% | 2.9% | - |
Executive Summary
Revenue and operating income remained largely flat, while ordinary income increased, supported by foreign exchange gains, and net income declined due to the recognition of extraordinary losses. Revenue was ¥467.1B (+0.2% YoY), operating income was ¥26.1B (+0.1%), ordinary income was ¥35.1B (+13.9%), and net income was ¥17.3B (-12.6%). The primary driver of the increase in ordinary income was the recognition of ¥9.9B in foreign exchange gains, while net income was weighed down by ¥11.6B in extraordinary losses, including ¥10.4B in disaster-related losses.
Factors Driving Earnings Performance
【Revenue】Revenue was ¥467.1B, essentially flat at +0.2% YoY. The core Precision Chemicals Business (79.8% of total) grew to ¥372.9B, up +0.7%; the Equipment Business increased to ¥33.7B, up +27.1%; and the Trading Business rose to ¥14.7B, up +16.8%. In contrast, the Basic Chemicals Business declined to ¥57.6B, down -3.9%, and the Iron-Based Business decreased to ¥13.9B, down -20.5%, resulting in divergent performance across businesses.
【Profit and Loss】Operating income was ¥26.1B, essentially flat at +0.1% YoY. While the core Precision Chemicals Business saw its segment profit decline to ¥21.2B (-15.3%) despite a slight increase in revenue, reflecting deteriorating profitability, the Basic Chemicals Business turned around from the previous year's loss (-¥5.2B) to a profit of ¥1.8B, supporting overall operating income. Ordinary income increased to ¥35.1B (+13.9%) due to the recognition of ¥9.9B in foreign exchange gains; however, net income declined to ¥17.3B (-12.6%) due to the recognition of ¥11.6B in extraordinary losses, including ¥10.4B in disaster-related losses, exceeding the ¥3.3B gain on the sale of investment securities. In conclusion, although revenue increased, improvement in core operating profitability was limited; ordinary income was affected by non-operating factors, while net income was affected by extraordinary losses, resulting in a phase of higher revenue but lower profit.
Segment Analysis
The Precision Chemicals Business is the core business, accounting for ¥372.9B in revenue (79.8% of the total) and ¥21.2B in segment profit (74.8% of the total), but its profit declined -15.3% YoY, indicating deteriorating profitability. The Basic Chemicals Business posted revenue of ¥57.6B (-3.9%), while turning around from a loss of ¥5.2B in the same period of the previous year to a profit of ¥1.8B. The Iron-Based Business recorded revenue of ¥13.9B (-20.5%) and profit of ¥1.96B (-29.2%), resulting in lower revenue and profit. The Equipment Business recorded revenue of ¥16.8B (+27.1%) and profit of ¥2.5B (-1.6%), while the Trading Business recorded revenue of ¥5.8B (+16.8%) and profit of ¥0.9B (-5.4%). In terms of profit margin, the Iron-Based Business is relatively high at 14.1%, but its revenue scale is small; recovery in the profitability of the Precision Chemicals Business will be key to improving consolidated earnings.
Key Financial Indicators
【Profitability】The operating margin was 5.6%, broadly at the same level as in the same period of the previous year, while the net margin remained at 3.7%. Under a cost structure consisting of a gross margin of 21.7% and an SG&A ratio of 16.1%, the operating margin has remained sluggish.【Cash Quality】Cash and deposits were ¥182.6B, notes and accounts receivable were ¥169.0B, and inventories were ¥68.7B, indicating that working capital is relatively large compared with revenue.【Investment Efficiency】ROE was 2.5% (trending lower compared with the actual result for the same period of the previous year). With total assets of ¥1,282.8B and revenue of ¥467.1B, the low asset turnover indicates that asset efficiency is constraining profitability.【Financial Soundness】The equity ratio remained high at 54.4%, and the financial base is stable under an interest-bearing debt structure centered on long-term borrowings of ¥300.2B.
Cash Flow Analysis
Because detailed figures from the cash flow statement are not included in the disclosed information, funding trends are analyzed based on changes in the balance sheet. While cash and deposits declined to ¥182.6B from ¥202.9B in the same period of the previous year, property, plant and equipment increased to ¥538.6B, and construction in progress remained at a certain level, suggesting that capital expenditures are continuing. Notes and accounts receivable of ¥169.0B and inventories of ¥68.7B have both tended to increase from the previous year, potentially indicating that the accumulation of working capital is putting pressure on cash on hand. Long-term borrowings increased to ¥300.2B, suggesting that some capital expenditures and working capital are being financed with long-term funds. Cash holdings provide sufficient coverage against current liabilities of ¥262.0B, leaving room for short-term liquidity management.
Quality of Earnings
The gap between ordinary income of ¥35.1B and pretax income of ¥26.8B was ¥8.3B, equivalent to 23.5% of ordinary income. This gap resulted from the recognition of ¥3.3B in extraordinary gains, including a ¥3.3B gain on the sale of investment securities, and ¥11.6B in extraordinary losses, including ¥10.4B in disaster-related losses and ¥1.1B in losses on the disposal of fixed assets. The scale of these extraordinary losses was equivalent to approximately 48% of net income of ¥17.3B, indicating that net income for the period was strongly affected by temporary factors. Of ¥15.5B in non-operating income, foreign exchange gains were the largest item at ¥9.9B, equivalent to 37.8% of operating income of ¥26.1B. It should be noted that the increase in ordinary income depended not on an improvement in core earnings power but on foreign exchange, a highly volatile non-operating factor. Comprehensive income was ¥32.5B, exceeding net income by ¥15.3B, due to a ¥20.1B increase from valuation differences on securities; this should be distinguished from results generated by business activities.
Earnings Forecast and Guidance
The progress rates against the full-year forecast for cumulative Q3 were 70.2% for revenue (forecast: ¥665.0B), 58.0% for operating income (forecast: ¥45.0B), and 66.2% for ordinary income (forecast: ¥53.0B). Revenue progress was generally at a steady level, but operating income progress was 17 percentage points below the standard 75% level, while ordinary income progress was similarly below that level. The earnings forecast was revised during the quarter, and the plan assumes an increase in profit in Q4. There was no revision to the dividend forecast, and the annual dividend remains unchanged at ¥18.00.
Shareholder Returns
The Q2 dividend was ¥9.00 per share, and the full-year forecast dividend is ¥18.00. Based on cumulative Q3 net income attributable to owners of the parent of ¥1.72B, the payout ratio based on the interim dividend actually paid can be calculated; the annual payout ratio against forecast full-year net income of ¥2.70B is approximately 38.3%. No disclosure has been made regarding share repurchases, and the Total Return Ratio has not been calculated. Although the payout ratio itself is at a conservative level, operating income progress toward the full-year forecast is only 58.0%, meaning that securing the funds for dividends will depend on the degree to which profit targets are achieved in Q4.
Risk Factors
-
Deteriorating profitability in the core business: The Precision Chemicals Business is the core business, accounting for 74.8% of consolidated segment profit, but segment profit deteriorated by -15.3% YoY. A delay in the recovery of profitability in this business would have a significant impact on consolidated operating income.
-
Foreign exchange sensitivity: Foreign exchange gains of ¥9.9B are equivalent to 37.8% of operating income, and the increase in ordinary income depends on this non-operating factor. Ordinary income could be pressured if foreign exchange rates reverse.
-
Recognition of extraordinary losses: The Company recorded ¥11.6B in extraordinary losses during the period, including ¥10.4B in disaster-related losses, which pressured net income. The possibility of recurrence and the status of facility safety systems will be factors affecting future earnings volatility.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 5.6% | 8.6% (4.3%–12.7%) | −3.0pt |
| Net Margin | 3.7% | 6.4% (2.8%–10.3%) | −2.7pt |
Both the operating margin and net margin are below the industry median, indicating that profitability is relatively low within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 0.2% | 3.3% (-2.1%–8.9%) | −3.1pt |
The revenue growth rate is also below the industry median, placing top-line growth among the more moderate levels within the industry.
※Source: Compiled by the Company
Key Takeaways from the Earnings
-
The increase in ordinary income was primarily attributable to ¥9.9B in foreign exchange gains. Given that operating income was essentially flat, this should be distinguished from an improvement in core earnings power.
-
Segment profit in the Precision Chemicals Business, the core of consolidated earnings, deteriorated by -15.3% YoY, making the direction of profitability recovery in this business a key area of focus going forward.
-
Operating income progress toward the full-year forecast remained at 58.0%, below the standard progress level, making the achievement of the profit target in Q4 a key area of attention.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear (Bearish) | ¥997 |
| base (Base) | ¥1,008 |
| bull (Bullish) | ¥1,018 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥1,185 |
| Adjusted Forecast EPS | ¥50.5 |
| Cost of Equity r | 9.77% (10-year Japanese government bond 2.77% + Equity Risk Premium 6.00% + Size Premium 1.00%) |
| Persistence Coefficient of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 38.3% |
| Forecast EPS Reliability Adjustment | ×1.075 (based on the historical guidance achievement rate of comparable companies in the same industry) |
| Implied PBR / PER | 0.85x / 19.9x |
Sensitivity: ¥981–¥1,037 at Cost of Equity ±1%, and ¥1,003–¥1,012 at ω±0.1.
Notes:
- Because forecast ROE is below the Cost of Equity, the theoretical value is below book value per share.
- Net assets as of the quarter-end are used (there is a timing difference relative to the full-year forecast).
(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated using only publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, nor does it predict or guarantee future share prices.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, consulting a professional as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was operationally stable but underlying earnings conversion weakened, with reported profit depressed by a large extraordinary loss. Revenue was ¥46.71bn, up 0.2% year on year, and operating income was essentially flat at ¥2.61bn, up 0.1%. Gross profit increased 3.1% to ¥10.14bn as cost of sales declined 0.6% despite flat sales. The gross margin expanded by 62bp to 21.7% from 21.1% in the prior-year period. However, SG&A expense rose 4.2% to ¥7.53bn, substantially faster than revenue growth. Consequently, the operating margin was broadly unchanged at 5.6%, down roughly 1bp year on year. Ordinary income rose 13.9% to ¥3.51bn, lifting the ordinary-income margin by about 90bp to 7.5%. This improvement was driven principally by ¥0.99bn of foreign-exchange gains, versus ¥0.24bn a year earlier. Net income attributable to owners fell 7.8% to ¥1.72bn and EPS declined to ¥30.04 from ¥32.53. The main reason was a net extraordinary loss of ¥0.83bn, compared with a small net extraordinary gain of ¥0.06bn in the prior-year period. Extraordinary losses included a ¥1.04bn disaster loss and ¥0.12bn loss on disposal of fixed assets, partly offset by a ¥0.33bn gain on sales of investment securities. Comprehensive income nevertheless increased 81.3% to ¥3.25bn, supported by positive valuation effects on securities and foreign-currency translation adjustments. Precision Chemicals remained the core business, accounting for roughly 75% of segment operating profit before eliminations. The full-year operating-income forecast of ¥4.50bn implies that Q4 operating income must reach approximately ¥1.89bn, materially above the ¥0.87bn average quarterly pace achieved through Q3. Management has revised its forecast, and the Q3 run-rate indicates that delivery of the revised earnings plan depends on a pronounced fourth-quarter acceleration. The balance sheet remains liquid and adequately capitalized, but low capital efficiency and extended working-capital days constrain the quality of returns.
Profitability Analysis
The reported annualized DuPont ROE is 3.3%, comprising a 3.7% net profit margin, 0.486x asset turnover, and 1.84x financial leverage. The low ROE is principally a margin and asset-utilization issue rather than a shortage of leverage: the balance sheet employs only moderate financial leverage. The operating margin of 5.6% is above the 5% concern threshold but remains modest for the capital base, while the 3.7% net margin is reduced by extraordinary losses and a 35.4% effective tax rate. Gross-margin expansion to 21.7% demonstrates improved production-level profitability, but the benefit was absorbed by SG&A growth of 4.2% against only 0.2% sales growth. This adverse operating-leverage pattern left operating income flat. The most significant movement below operating profit was the increase in FX gains to ¥0.99bn, equivalent to 37.8% of operating income, which explains much of the ordinary-income growth but is not a dependable operating driver. Interest coverage of 7.37x remains sound, and the five-factor interest burden of 1.029 reflects non-operating income exceeding interest expense rather than immediate debt-service stress. The tax burden of 0.643 is below a normal 0.70 benchmark, reflecting the relatively high 35.4% effective tax rate. The reported ROIC of 2.7% is below the 5% warning threshold and is the central capital-efficiency concern. Segment performance was mixed: Basic Chemicals turned from a ¥0.52bn loss to a ¥0.18bn profit despite sales declining 3.9% to ¥5.77bn; Precision Chemicals sales rose 0.7% to ¥37.29bn but segment profit declined 15.3% to ¥2.12bn; Iron-related sales fell 20.5% to ¥1.39bn and profit fell 29.2% to ¥0.20bn; Trading sales rose 16.8% to ¥0.58bn while profit declined 5.4% to ¥0.09bn; and Facilities sales rose 27.1% to ¥1.68bn while profit declined 1.6% to ¥0.25bn. Precision Chemicals remains the core earnings engine, but its profit decline despite modest sales growth indicates margin pressure within the group’s largest business.
Growth Assessment
Revenue growth of 0.2% indicates a broadly flat top-line environment rather than broad-based expansion. The improvement in gross profit despite flat revenue is constructive, but the failure to translate this into operating-profit growth highlights cost discipline as the immediate earnings variable. Basic Chemicals' return to profitability is a favorable change in mix, although its ¥0.18bn segment profit remains small relative with Precision Chemicals' ¥2.12bn. Precision Chemicals generated virtually all group operating profit before segment eliminations, making the group highly sensitive to pricing, volume, and product mix in that business. The 20.5% revenue contraction in Iron-related operations is a material drag and exposes the group to cyclicality in industrial demand. Facilities delivered the strongest revenue growth, but its operating profit remained virtually flat, implying limited incremental margin capture. Full-year forecast progress is 70.2% for revenue, 58.0% for operating income, 66.2% for ordinary income, and 63.9% for net income attributable to owners. Against a normal 75% Q3 progress benchmark, operating-income progress is 17.0 percentage points behind and net-income progress is 11.1 points behind, while ordinary-income progress is 8.8 points behind. The implied Q4 operating margin is approximately 9.5%, compared with 5.6% through Q3, making the forecast dependent on substantially improved volume, mix, pricing, costs, or timing of project recognition. The implied Q4 ordinary income of ¥1.79bn would also require continued support from non-operating items or a sharp operating improvement. The forecast calls for full-year sales growth of 6.7% and operating-income growth of 5.3%, so forecast execution requires growth well above the cumulative Q3 trend.
Financial Health
Liquidity is strong, with a current ratio of 234.2%, a quick ratio of 208.0%, and working capital of ¥35.17bn. Cash and deposits of ¥18.26bn cover short-term loans by 6.68x, providing a substantial near-term liquidity cushion. Current assets of ¥61.37bn are more than double current liabilities of ¥26.20bn, limiting maturity-mismatch risk. Interest-bearing debt totals ¥32.75bn, of which long-term loans are ¥30.02bn, and the reported short-term debt ratio is only 8.4%; debt is therefore predominantly termed out rather than concentrated in near-term refinancing. Debt-to-equity is 0.84x, below the 1.0x conservative benchmark, while debt-to-capital is 32.0%, below the 40% investment-grade reference point. Interest coverage of 7.37x supports the current debt burden. Long-term loans increased by ¥5.53bn year on year, or 21.6%, and should be monitored alongside the company’s investment program even though leverage remains manageable. Investment securities increased by ¥2.80bn, or 34.2%, to ¥10.98bn and now represent 8.6% of total assets; this increases exposure to market-value movements, although positive securities valuation effects supported comprehensive income in the period. Treasury stock increased from ¥0.62bn to ¥1.59bn, a ¥0.97bn increase in the contra-equity balance, consistent with additional repurchases or similar capital actions. PPE represents 42.0% of assets, confirming the capital-intensive nature of the manufacturing base. Construction in progress declined by ¥11.35bn, or 66.0%, to ¥5.87bn, while buildings rose ¥4.30bn and machinery rose ¥5.81bn; this pattern indicates commissioning or transfer of projects from construction into operating assets. No material goodwill concentration is evident from the reported intangible-asset balance of ¥0.65bn, equal to only 0.5% of assets.
Notable B/S Changes
Investment securities: +¥2.80bn (+34.2%) to ¥10.98bn - increases exposure to securities-market valuation changes and supported positive OCI during the period. Treasury stock: ¥0.62bn to ¥1.59bn in contra-equity balance (+¥0.97bn; 156.5% increase) - indicates a larger capital return or treasury-share position. Construction in progress: -¥11.35bn (-66.0%) to ¥5.87bn - suggests substantial completion and transfer of investment projects into productive fixed assets. Buildings: +¥4.30bn (+30.6%) to ¥18.35bn - reflects commissioning of capital projects and raises the need to monitor utilization and return generation. Machinery and equipment: +¥5.81bn (+32.5%) to ¥23.69bn - expands the operating asset base; future earnings must improve to raise ROIC from 2.7%.
Cash Flow Quality
The working-capital profile is the principal cash-conversion concern. Annualized receivable days are 99 days, above the 60-day warning threshold, indicating slow collection relative to manufacturing benchmarks. Annualized inventory days are 152 days, above the 90-day warning threshold, and point to substantial capital tied up in production and stock. The annualized cash conversion cycle is 207 days, well above the 120-day warning threshold. These three quality alerts suggest that a meaningful portion of operating capital is locked in customer receivables and inventory, raising sensitivity to demand changes, customer collection delays, and inventory obsolescence. Trade receivables rose ¥2.53bn year on year to ¥16.90bn, while accounts payable declined ¥0.50bn to ¥5.94bn, a combination that is unfavorable for operating cash conversion. Raw materials increased to ¥6.59bn and work in process to ¥6.86bn, while finished goods were ¥6.87bn; the elevated inventory cycle should be assessed against production plans and demand visibility. The short-term liquidity position is strong enough to absorb this working-capital intensity, but sustained improvement in collections, production scheduling, and inventory turnover would be important for capital efficiency.
Dividend Sustainability
The stated full-year dividend forecast is ¥18.00 per share, comprising the ¥9.00 interim dividend and an implied ¥9.00 year-end dividend. Based on forecast EPS of ¥47.03, the forecast dividend payout ratio is approximately 38.3%, below the 60% sustainability benchmark. The ¥9.00 interim dividend represents a 30.0% payout ratio against cumulative Q3 earnings as calculated in the supplied data. Retained earnings of ¥552.24bn provide a substantial accounting buffer relative to the expected dividend commitment. The forecast payout remains compatible with the company’s moderate 0.84x debt-to-equity ratio and strong liquidity metrics. However, sustainable dividend growth ultimately depends on improving the 2.7% ROIC and reducing the long cash conversion cycle, rather than relying on foreign-exchange gains or investment-security sale gains. Treasury stock increased during the period, so any assessment of shareholder distributions beyond dividends should be framed as a total return ratio rather than a payout ratio.
Risk Assessment
Business risks include Precision Chemicals is the core earnings contributor, so its 15.3% segment-profit decline despite 0.7% sales growth creates concentrated margin risk., Iron-related revenue fell 20.5% year on year, highlighting exposure to cyclical industrial demand and customer production trends., FX gains of ¥0.99bn were equal to 37.8% of operating income. This exceeds the 20% warning threshold, indicating that currency movements can materially alter ordinary earnings even when operating performance is flat., As a chemical manufacturer, the group is exposed to energy and raw-material cost volatility, process-safety requirements, environmental regulation, and potential disruption from plant incidents; the reported disaster loss illustrates operational-event sensitivity..
Financial risks include Annualized DSO of 99 days exceeds the 60-day warning level. Slow collection elevates funding needs and raises exposure to customer-credit deterioration., Annualized DIO of 152 days exceeds the 90-day warning level. High inventory intensity creates risks of destocking, valuation losses, and weak cash generation if demand slows., The 207-day annualized cash conversion cycle exceeds the 120-day warning level. This is a material structural drag on cash efficiency despite strong reported liquidity., Long-term loans increased ¥5.53bn year on year to ¥30.02bn. Current leverage is manageable, but future returns must justify the additional capital employed., Investment securities increased 34.2% to ¥10.98bn, increasing sensitivity of equity and comprehensive income to market-price movements..
Key concerns include ROIC of 2.7% is below the 5% warning threshold, indicating that earnings are not yet generating an adequate return on the capital base., Operating-income forecast progress is only 58.0% at Q3, 17.0 percentage points below the standard 75% pace; the plan requires an implied Q4 operating margin near 9.5%., SG&A grew 4.2% while revenue grew only 0.2%, preventing gross-margin improvement from producing operating leverage., The gap between ordinary-income growth of 13.9% and net-income decline of 7.8% reflects volatility from FX and extraordinary items rather than a broad improvement in recurring earnings..
Investment Implications
Key takeaways include Gross-margin improvement and Basic Chemicals' return to profitability are positive, but group operating profit remains stagnant., Precision Chemicals remains the dominant profit source, making recovery in its segment margin central to group earnings improvement., Balance-sheet liquidity, moderate leverage, and 7.37x interest coverage provide resilience during a period of subdued operating returns., Capital efficiency and working-capital discipline are the key fundamental constraints, as reflected in 2.7% ROIC and a 207-day annualized cash conversion cycle., The full-year forecast requires a material Q4 earnings acceleration and should be judged against actual margin recovery rather than FX-driven ordinary-income support..
Metrics to watch include Precision Chemicals segment profit and margin trend, Q4 operating income versus the approximately ¥1.89bn implied requirement, Foreign-exchange gains or losses relative to operating income, Annualized DSO, DIO, and cash conversion cycle, ROIC improvement from the current 2.7%, Long-term debt trend and returns on newly commissioned PPE, Investment securities valuation movements and realized gains.
Regarding relative positioning, The company combines strong liquidity and conservative-to-moderate leverage with weak capital productivity. Its 5.6% operating margin is above the defined concern threshold but below the level associated with strong manufacturing profitability, while the 3.3% annualized ROE and 2.7% ROIC lag return benchmarks. The capital-intensive asset base and unusually long working-capital cycle make operational execution and asset utilization more important than balance-sheet survival.